22nd Century Group Inc
XXII
Company Profile
Business description
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
Contact
321 Farmington Road
MocksvilleNC27028
USAT: +1 336 940-3769
Sector
Consumer Defensive
Stock type
Defensive
Industry
Tobacco
Fiscal Year End
31 December 2025
Employees
56
Stocks News & Analysis
stocks
10 best US dividend aristocrats to buy now—including a surprise outperformer
These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.
stocks
Leading ASX players in this field look materially overvalued
We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.
stocks
After earnings, is Alphabet stock a buy, a sell, or fairly valued?
With a diverse portfolio of innovative technology and integrated media platforms, here’s what we think of Alphabet’s stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,994.70 | 20.70 | -0.23% |
| CAC 40 | 7,861.96 | 4.60 | 0.06% |
| DAX 40 | 24,262.22 | 44.85 | 0.19% |
| Dow JONES (US) | 44,461.28 | 171.71 | -0.38% |
| FTSE 100 | 9,136.94 | 0.62 | 0.01% |
| HKSE | 24,879.66 | 297.27 | -1.18% |
| NASDAQ | 21,129.67 | 31.38 | 0.15% |
| Nikkei 225 | 40,960.45 | 305.75 | 0.75% |
| NZX 50 Index | 12,830.37 | 25.60 | -0.20% |
| S&P 500 | 6,362.90 | 7.96 | -0.12% |
| S&P/ASX 200 | 8,738.30 | 18.10 | -0.21% |
| SSE Composite Index | 3,591.26 | 24.46 | -0.68% |